{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-223656","form_type":"8-K","ticker":"VRDN","cik":"0001590750","company_name":"Viridian Therapeutics, Inc.\\DE","filed_at":"2021-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.709816+00:00","generated_at":"2026-06-30T02:35:33.557961+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Viridian Therapeutics appoints Kristian Humer as CFO and CBO, effective July 26, 2021","bullets":["Mr. Humer will receive an annual base salary of $530,000, a sign-on bonus of $400,000, and a target bonus of 45% of base salary.","He received an initial equity grant of options to purchase 360,000 shares, vesting over four years.","Mr. Humer previously served as Managing Director in the Global Healthcare team at Citigroup Inc.","The inducement grant was approved by a majority of independent directors in accordance with Nasdaq Listing Rule 5635(c)(4)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-223656","json":"https://secwatch.observer/filing/0001193125-21-223656.json","markdown":"https://secwatch.observer/filing/0001193125-21-223656.md","text":"https://secwatch.observer/filing/0001193125-21-223656.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590750/000119312521223656/0001193125-21-223656-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590750/000119312521223656/d182412d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T02:35:33.557961+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7d323b3773","claim":"Kristian Humer was appointed as Chief Financial Officer and Chief Business Officer at Viridian Therapeutics, Inc.\\DE.","evidence_excerpt":"On July 26, 2021, Viridian Therapeutics, Inc. (the “Company”) announced the appointment of Kristian Humer as the Company’s Chief Financial Officer and Chief Business Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590750/000119312521223656/0001193125-21-223656-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}